Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Other Non-Current Assets (2010 - 2026)

Omnicell's (OMCL) quarterly Other Non-Current Assets came in at $65.7 million in Q2 2026, down 8.85% year-over-year from $72.0 million in Q2 2025, and down 2.8% quarter-over-quarter from $67.5 million in Q1 2026.

Analysis

Omnicell (OMCL) Other Non-Current Assets (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Other Non-Current Assets for 17 consecutive years, with $65.7 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Other Non-Current Assets fell 8.85% year-over-year to $65.7 million in Q2 2026; TTM through Jun 2026 was $65.7 million, a 8.85% decrease from a year earlier, with the FY2025 full-year figure at $70.2 million, down 11.48% from the prior year.
  • Other Non-Current Assets was $65.7 million for Q2 2026 at Omnicell, down from $67.5 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $122.1 million in Q1 2022 and troughed at $65.7 million in Q2 2026.
  • A 5-year average of $88.1 million and a median of $84.7 million in 2024 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets rose 3.1% in 2022 and decreased 17.88% in 2023, its largest moves.
  • Over 5 years, Other Non-Current Assets stood at $105.0 million in 2022, then slipped by 13.86% to $90.5 million in 2023, then declined by 12.34% to $79.3 million in 2024, then slipped by 11.48% to $70.2 million in 2025, then dropped by 6.48% to $65.7 million in 2026.
  • The last three Other Non-Current Assets figures came in at $65.7 million (Q2 2026), $67.5 million (Q1 2026), and $70.2 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 4.32 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 3.23 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 616.40 Mn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 434.00 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 273.70 Mn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn 457.39 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn 65.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 65.66 Mn
Mar 31, 2026 67.55 Mn
Dec 31, 2025 70.20 Mn
Sep 30, 2025 70.09 Mn
Jun 30, 2025 72.03 Mn
Mar 31, 2025 76.56 Mn
Dec 31, 2024 79.31 Mn
Sep 30, 2024 81.73 Mn
Jun 30, 2024 83.05 Mn
Mar 31, 2024 86.32 Mn
Dec 31, 2023 90.47 Mn
Sep 30, 2023 90.77 Mn
Jun 30, 2023 96.79 Mn
Mar 31, 2023 100.47 Mn
Dec 31, 2022 105.02 Mn
Sep 30, 2022 110.35 Mn
Jun 30, 2022 117.86 Mn
Mar 31, 2022 122.12 Mn
Dec 31, 2021 127.52 Mn
Sep 30, 2021 120.48 Mn